Few areas of wellness care have drawn as much attention in recent years as peptide therapy, and few have generated as much confusion. Patients in Anaheim Hills and across Orange County now encounter peptides in podcasts, fitness forums, and social media advertisements, often described with a level of certainty that the medical literature does not yet support. At Dr. Shadi Concierge MedSpa & Wellness, we believe patients deserve a clearer picture: which peptides are backed by large clinical trials, which are supported mainly by laboratory and animal research, and which carry real uncertainty about safety and regulation. Dr. Shadi Kranitz, M.D., a former pediatric oncologist who entered aesthetics after her own cancer diagnosis, approaches this topic with the caution of someone who has spent her career weighing evidence on behalf of patients. That perspective shapes every peptide conversation we have in our Anaheim Hills office.
Understanding Peptides as Medicine: Three Very Different Categories
Peptides are short chains of amino acids that act as signaling molecules in the body, instructing cells to release hormones, regulate appetite, modulate inflammation, or begin tissue repair. Insulin, oxytocin, and glucagon are all peptides, which is a useful reminder that the word itself describes a type of molecule rather than a particular treatment or promise. When patients ask about peptide therapy, they are often asking about several very different things at once. We find it helpful to sort the field into three broad categories, because the level of evidence and oversight differs substantially from one to the next.
FDA-Approved Peptide Medications
The first category includes peptide drugs that have completed the full FDA approval process, with randomized controlled trials evaluating both safety and effectiveness for a specific indication. The GLP-1 and dual GIP/GLP-1 receptor agonists used in metabolic medicine, such as semaglutide and tirzepatide, belong here, as does tesamorelin, which is approved for a specific form of abdominal fat accumulation in adults living with HIV. In a 2026 review in the International Journal of Molecular Sciences, Renke and Chinellato concluded that therapeutic peptides are a promising tool for type 2 diabetes, obesity, skin rejuvenation, and as hormone analogs for specific conditions, while also noting that further studies are needed before most newer peptides can be used safely in humans. That distinction between the established and the emerging is central to how we counsel patients.
Compounded and Investigational Peptides
The second category includes peptides that are prepared by licensed compounding pharmacies but have not been approved by the FDA for the uses patients most often ask about. Many of the names patients recognize, including BPC-157, TB-500, MOTS-c, Epithalon, Selank, and Semax, fall into this group. Their regulatory status for compounding has been reviewed by the FDA’s Pharmacy Compounding Advisory Committee, and Willis and Vu, writing in the International Journal of Pharmaceutical Compounding in 2026, examined the concerns raised during that review and what they mean for pharmacies. Because this landscape continues to shift, we review current status with each patient rather than assuming that what was true last year remains true today.
Unregulated Online Products
The third category is the one we are most concerned about: peptides sold online as research chemicals, often labeled not for human use, with no pharmacy oversight. Moiz, O’Keefe, and O’Keefe, in a 2026 review in Missouri Medicine, described risks from this gray market that include product contamination, manufacturing impurities, and inaccurate dosing. Our practice does not use products from this category, and we encourage any patient currently using them to discuss it openly with a physician.
Why Patients in Orange County Are Asking About Peptides
The concerns that bring patients to us are rarely abstract. Many are women in perimenopause or menopause who describe fatigue, disrupted sleep, weight changes, brain fog, or slower recovery from exercise, and who feel that their concerns have been dismissed elsewhere. Others are active adults frustrated by nagging injuries, or patients focused on skin quality and healthy aging who have read that peptides may support collagen. Each of these concerns is legitimate, and each deserves a careful medical evaluation before any therapy is considered.
When Symptoms Point to Something Else
Symptoms like fatigue and cognitive fog have many possible causes, including thyroid dysfunction, anemia, sleep apnea, depression, hormonal transition, and medication side effects. Part of our role is to make sure a peptide conversation does not replace an appropriate workup. In some cases, a patient may be better served by our hormone therapy program, a referral to a specialist, or simple adjustments to sleep, nutrition, and training. We would rather identify the right problem than prescribe a product for the wrong one.
A Personal Lens on Caution
Dr. Kranitz’s experience as both a physician and a cancer survivor gives her a particular sensitivity to questions about growth signaling and long-term safety. Some investigational peptides are promoted for their ability to stimulate blood vessel growth or tissue proliferation, and the Missouri Medicine review cited above lists pathological angiogenesis and carcinogenesis among the theoretical concerns that remain unresolved. For patients with a personal or strong family history of cancer, these questions are not academic. We discuss them directly and respectfully, and we recognize that every patient brings different cultural values and comfort levels to decisions about their health.
How We Evaluate and Personalize Peptide Therapy
Our Signature approach to peptide care begins with a physician consultation rather than a product menu. Dr. Kranitz reviews your medical history, current medications, symptoms, goals, and when appropriate, laboratory results, before discussing whether any peptide is a reasonable option. Our physician-led clinical team then explains what the evidence shows for that specific peptide, what remains uncertain, and what alternatives exist. As our own peptide therapy page states, the peptide therapies we offer are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease, and we say the same thing plainly in person.
Matching the Evidence to the Goal
The quality of evidence varies widely by peptide and by goal. For recovery-focused peptides discussed on our recovery and immunity peptide page, much of the research remains preclinical. Mateescu and colleagues, in a 2026 review in Pharmaceutics, described BPC-157 as an investigational peptide and outlined the formulation and translational barriers that still separate animal findings from established human use. Mendias and Awan, writing in Sports Medicine in 2026, similarly noted that several popular unapproved peptides show promise in animal models but that rigorous human safety data are scarce. For GHK-Cu, a copper peptide with a long history in skin care, Mortazavi and colleagues reported in Bioimpacts in 2025 that cellular studies support its role in collagen synthesis but that clinical studies remain surprisingly limited.
Longevity, Cognitive, and Metabolic Goals
Patients interested in energy and healthy aging often ask about the options listed on our longevity and energy peptide page, while others are curious about the approaches described on our brain health peptide page. We are candid that these are areas of active exploration rather than settled medicine. For patients whose primary goal is weight management, FDA-approved GLP-1 medications offered through our medical weight loss program have a far deeper evidence base, and we often discuss that path first.
When Peptide Therapy Is Not Appropriate
We fold candidacy into every step of the consultation rather than treating it as a checklist. Peptide therapy is generally not appropriate during pregnancy or breastfeeding, and we approach it with significant caution, or decline it, for patients with active cancer, a recent cancer history, uncontrolled chronic illness, or complex medication regimens where interactions are poorly understood. Patients seeking rapid or dramatic change, or those hoping peptides will replace sleep, nutrition, and exercise, are usually better served by a different plan. In these situations, declining to prescribe is part of responsible care.
What to Expect
If you and Dr. Kranitz decide together that a peptide may be reasonable to try, the process is deliberate and closely monitored. We document a baseline of your symptoms and goals, prescribe only through a licensed pharmacy, and schedule follow-up visits to review how you are feeling, any side effects, and whether continuing makes sense. Injection-site redness, mild swelling, headache, or changes in appetite may occur with some peptides, and we ask patients to report any unexpected symptoms promptly. Most plans are time-limited, with clear criteria for stopping if the expected benefit does not appear.
Realistic Timelines
Results, when they occur, tend to be gradual and variable. Some patients describe subtle improvements in energy, sleep, or recovery over several weeks, while others notice little change, and we treat both outcomes as useful information. Mendias and Awan also discussed the placebo effect as a meaningful mediator of reported peptide benefits, amplified by social media, which is one reason we rely on consistent tracking rather than impressions alone. Our goal is balance and sustainable wellness, never overcorrection.
Questions Worth Asking Any Provider
Because peptide therapy is offered in many settings, from medical practices to gyms to online platforms, we encourage patients to ask the same questions wherever they seek care. Who is prescribing, and what is that person’s medical training? Which pharmacy prepares the product, and is it a licensed, state-regulated facility? What does the published research actually show for this peptide in humans, and what is the plan if it does not help? A thoughtful provider will welcome these questions and answer them without pressure.
Why Physician Oversight Matters
Physician oversight is not a formality. It means someone with medical training is reviewing your full history, recognizing when symptoms point to a different diagnosis, monitoring for side effects, and deciding when to stop. At Dr. Shadi Concierge MedSpa & Wellness, Dr. Shadi Kranitz personally leads these decisions, supported by our clinical team, and you can learn more about the people behind our care on our staff page. This concierge-level model allows us to spend the time that careful peptide counseling requires.
Schedule a Peptide Therapy Consultation in Anaheim Hills
If you have been reading about peptides and want an honest, physician-led conversation about whether any of them fit your health goals, we welcome you to visit our office at 5769 E Santa Ana Canyon Rd, Suite K, in Anaheim. We care for patients from Anaheim Hills, Yorba Linda, Orange, Placentia, Brea, Fullerton, and communities throughout Orange County. You can call us at (714) 600-2262 or contact Dr. Shadi Concierge MedSpa & Wellness to request an appointment with Dr. Kranitz. You will leave with a clear understanding of what the evidence supports, what remains uncertain, and a plan that reflects your values and your health history.
